Urgent.News

600+ sources. One page. See who else covered it.

Editions

Finance & Markets

Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs

Pfizer said it cut its full-year revenue expectation for its Covid products to $4 billion, down from around $5 billion previously.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Finance & Markets

More from Tuesday 4 August →